BackSymBio Pharmaceuticals Limited Overview
SymBio Pharmaceuticals Limited

SymBio Pharmaceuticals Limited Return on Equity

SymBio Pharmaceuticals Limited (4582.T) has a ROE of 1062.3%, above the sector sector average of 11.85%.

Get informed when a big investor buys or sells

+ Follow

ROE

1062.30%

Return on Equity

1062.30%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

SymBio Pharmaceuticals Limited (4582.T) FAQ

As of the most recent data, 4582.T shows a ROE of 1062.3%. That is above the sector sector average of 11.85%. Scroll down for historical charts and peer comparison views.

The its sector sector average ROE is about 11.85%. SymBio Pharmaceuticals Limited is at 1062.3%, which is higher that average. That is roughly 8862.9% above the sector mean. Use the comparison chart on this page to see how 4582.T stacks up against individual peers as well.

Check the historical chart to see whether 4582.T's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare SymBio Pharmaceuticals Limited with peers to see if the move is company-specific or sector-wide.

Besides this return on equity page, Stockcircle has SymBio Pharmaceuticals Limited's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently 1062.3%) with ownership activity and broader fundamentals.